Company Tagline
We are dedicated to developing and providing novel antibiotic resistance breakers to the global market.
Industry Category
Business Keywords
Company Description
AdjuTec Pharma AS is dedicated to the development and provision of innovative antibiotic resistance solutions to address the growing global challenge of antimicrobial resistance. AdjuTec Pharma AS focuses on creating advanced therapies to enhance the effectiveness of existing antibiotics.
AdjuTec Pharma AS's core technology involves the synthesis of β-lactamase inhibitors (BLIs) that effectively neutralize bacterial resistance enzymes. By overcoming bacterial defense mechanisms, AdjuTec Pharma AS aims to restore the susceptibility of broad-spectrum antibiotics, ensuring their continued efficacy in treating infections. The primary address of AdjuTec Pharma AS is Universitetsgata 2, Oslo, 0164, NO.
With a strong commitment to innovation and public health, AdjuTec Pharma AS is poised to make a significant impact on the future of antibiotic therapy. The company is supported by national and EU-grants as well as private funding, and is scheduled to commence clinical development of its lead product, APC148, in September 2024. We invite the manager of AdjuTec Pharma AS to create a customized and exclusive company showcase and product listing on our platform.
AdjuTec Pharma AS er dedikert til utvikling og levering av innovative antibiotikaresistensløsninger for å møte den voksende globale utfordringen med antimikrobiell resistens. AdjuTec Pharma AS fokuserer på å skape avanserte terapier for å forbedre effektiviteten av eksisterende antibiotika.
AdjuTec Pharma AS sin kjerneteknologi involverer syntese av β-laktamasehemmere (BLI) som effektivt nøytraliserer bakterielle resistensenzymer. Ved å overvinne bakterielle forsvarsmekanismer, har AdjuTec Pharma AS som mål å gjenopprette følsomheten til bredspektrede antibiotika, og sikre deres fortsatte effekt i behandlingen av infeksjoner. Hovedadressen til AdjuTec Pharma AS er Universitetsgata 2, Oslo, 0164, NO.
Med en sterk forpliktelse til innovasjon og folkehelse, er AdjuTec Pharma AS klar til å ha en betydelig innvirkning på fremtiden for antibiotikabehandling. Selskapet støttes av nasjonale og EU-tilskudd samt privat finansiering, og er planlagt å starte klinisk utvikling av sitt ledende produkt, APC148, i september 2024. Vi inviterer lederen av AdjuTec Pharma AS til å opprette en tilpasset og eksklusiv firmapresentasjon og produktliste på vår plattform.
Key Personnel / Employees
Similar Companies
Other organizations in the same industry
Euro Pharma International
Pharmaceutical-ManufacturingEuro Pharma International Medical Devices, Pharmaceuticals, Herbal Products & Cosmetics
Galephar Pharmaceutical Research, Inc.
Pharmaceutical-ManufacturingWe are a company dedicated to the improvement of galenic preparations using the most advanced techno...
MW Lifesciences
Pharmaceutical-Manufacturing🧪🔬💊Salutifer Orbi: Bringing Health to the World 🌐www.medisafe.lk 🌐www.todaycare.lk
Lifeguard Manufacturing (Pvt) Ltd
Pharmaceutical-ManufacturingWE CARE YOU
Alternative Company Names
This company is also known as